Setogepram

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameSetogepram
Drug Alias NameFezageprasPBI-4050
ClassificationSmall molecules
Mechanisms of ActionG-protein coupled receptor 84 antagonistsFree fatty acid receptor 1 antagonists
TargetsG-protein coupled receptor 84Free fatty acid receptor 1
Therapy Area/IndicationsInflammationHyperammonemiaFibrosis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrometic Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesLiminal Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsHyperammonemiaMetabolic SyndromeDiabetes Mellitus, Type 2 +[7] 

Other Information

ATC CodeN/A
Related LinksN/A